iCAD Inc. (ICAD)
3.10
0.07 (2.31%)
At close: Apr 22, 2025, 11:55 AM
2.31% (1D)
| Bid | 3.09 |
| Market Cap | 84.7M |
| Revenue (ttm) | 19.61M |
| Net Income (ttm) | -5.62M |
| EPS (ttm) | -0.21 |
| PE Ratio (ttm) | -14.74 |
| Forward PE | -21.47 |
| Analyst | n/a |
| Ask | 3.1 |
| Volume | 664,592 |
| Avg. Volume (20D) | 888,080 |
| Open | 3.04 |
| Previous Close | 3.03 |
| Day's Range | 3.04 - 3.11 |
| 52-Week Range | 1.18 - 3.78 |
| Beta | 1.78 |
About ICAD
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm tha...
Industry Medical - Devices
Sector Healthcare
IPO Date Dec 13, 1984
Employees 66
Stock Exchange NASDAQ
Ticker Symbol ICAD
Website https://www.icadmed.com
Next Earnings Release
iCAD Inc. is scheduled to release its earnings on May 14, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
+59.07%
iCAD shares are trading higher after the company a...
Unlock content with
Pro Subscription
5 days ago
+6.04%
iCAD shares are trading higher after the company announced it will be acquired by RadNet for a transaction value of approximately $103 million.
